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A benign tumor resembling differentiation toward 
early embryonic metanephric tubules. 
Classification 
Note 
Metanephric adenoma belongs to the category of 
Metanephric tumor in the WHO histological 
classification of tumors of the kidney. 
Clinics and pathology 
Epidemiology 
Metanephric adenomas are uncommon but occur 
across a wide range of patients, from infants to elder 
individual. The peak age frequency is 40 to 69 years. 
There is a female predominance (2.3:1). Ten percent 
of patients present with polycythemia. 
Clinics 
Mostly are incidentally discovered.  
Some patients present with hematuria and abdominal 
or flank pain. 
Pathology 
Grossly, the tumors are solid, gray to tan in color, and 
homogenous on cut surface.  
Most tumors are well-demarcated but lack a capsule.  
Microscopically, the tumor is chiefly composed of 
tightly packed primitive tubules and acina, with 
frequent papillary or glomeruloid structures.  
The individual tumor cells have scant cytoplasm, 
round-to-oval nuclei with smooth chromatin, 
inconspicuous nucleoli.  
Stromal hyalinization, dystrophic calcification and 
psammoma bodies are occasionally seen.  
Mitotic figures are rare or absent. The tumor cells are 
positive for WT1, PAX2 and CD57, but negative for 




The vast majority of metanephric adenomas behave 
in a benign fashion.  
Cases of regional lymph node metastasis and 
sarcomatoid changes have been individually reported. 
Cytogenetics 
Note 
Karyotyping of a total of five cases revealed negative 
findings, with the exception of a dual balanced 
translocation of t(1;22)(q22;13) and 
t(15;16)(q21;p13) in one case.  
Sporadic allelic imbalances involving chromosomes 
2p, 7, 8p, 12q, 16q, and 20q were identified in 18-
56% of cases.  
A deletion in chromosome 2p was described, and a 
tumor suppressor gene region on 2p13 was 
delineated.  
One study of array comparative genomic 
hybridization (aCGH) reported no copy number 
changes in six cases, while another study of a CGH 
on 9 cases showed normal chromosome copy number 
in 4, sporadic chromosomal imbalances in 3, and 
multiple chromosomal gains and losses in 2.  
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A. The tumor is composed of tubular and solid areas of uniform cells. B. The tumor is immunohistochemically positive for WT-1. 
 
The gain of chromosome 19 was the most common 
finding (five cases). The gains of chromosomes 7 and 
17 noted in papillary renal cell carcinoma, as well as 
the chromosome gains of 1q, 7q, and 12, and losses 
of 11p and 16q commonly seen in Wilms' tumor have  
 
 
not been detected in metanephric adenoma. It should 
be noted that the trisomies of chromosomes 7 and 17 
and loss of Y reported in the series of Brown et al. 
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